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 Whey protein isolate supplementation has been recognized as having potential for 
regulating appetite, thereby potentially improving mood and food intake. 
The objectives of this project were to 1) analyze the effects of high-quality whey protein 
intake on overall diet, and 2) identify and examine a correlation between tryptophan levels and 
mood regulation.  
This research was conducted using a randomized experimental design. A total of 13 post-
menopausal women (12+ months after last reported menstrual cycle) were recruited and 
allocated to one of two dietary intervention (DI) groups: 1) control (maintain current lifestyle; 
CON; n = 6), and 2) whey protein isolate (WPI; 25 g; n = 7).  Protein was consumed prior to 
10:00 am daily. Both interventions were followed daily for 16 weeks.  
All laboratory visits required participants to arrive fasted with complete 3-day dietary 
logs. Participants completed the Pittsburgh Sleep Quality Index (PSQI) and Profile of Moods 
Questionnaire. Height, weight, and waist-to-hip ratio was measured. A blood draw was 
administered to assess sleep and metabolic blood markers.  
One-way repeated measures analysis of variance (ANOVA) was used to assess the 
differences in BMI and POMS. One-way ANOVA was used to calculate the POMS Total Mood 
Disturbance scores. Clinical biomarker differences were determined through repeated-measures 
ANOVA (statistically significant: P < 0.05). Prism GraphPad Software Version 9.0 (La Jolla, CA) 
was used for all analyses. 
 Results were inconclusive. We found no correlation between daily whey protein isolate 
supplementation and tryptophan levels, overall diet, or mood regulation.  
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Introduction and Background 
The older adult population (≥65 years) in the United States is projected to double 
between 2017 and 2060 2. By 2030, it is projected that one out of every five Americans 3, or 
about 72 million people 4, will be of retirement age. The growing older adult population pays 
95% of its health care costs to treat chronic diseases such as cardiovascular disease, diabetes, and 
chronic lower respiratory disease 4. Chronic disease affects most older adults, and two out of 
three suffer multiple chronic diseases 4. Furthermore, in 2006, the Behavioral Risk Factor 
Surveillance System (BRFSS) indicated that in the state of Arkansas, 8.5-9.8% of adults 50 years 
of age or older experienced frequent mental distress (FMD) and 8.6-12.4% experienced 
depression 5. FMD and depression can prevent successful treatment of chronic disease 5 and 
negatively impact overall diet through inducing unhealthy cravings 6.  
As the older adult population doubles, evidence-based recommendations are needed to 
establish effective preventative nutrition recommendations for adults transitioning into the older 
adult life stage. It is especially important to develop recommendations for the subgroup of post-
menopausal women, as projections estimate that by 2030, 25% of the United States population 
will be women ages 45 and up 2. The study population of post-menopausal women has not yet 
been thoroughly studied. As the onset of menopause occurs typically between ages 42-55 7 and 
chronic diseases are often first diagnosed around age 50 4, the post-menopause time period is 
crucial for identifying and managing existing chronic disease. Post-menopausal women 
experience shifts in body composition, including an average 44% increase of visceral fat mass 
during menopause 7, 8,  which may affect the way nutrients, such as tryptophan, are utilized in the 
body.  This population also experiences disrupted sleep cycles and fluctuating mood, partially as 
a result of hormone levels 8. 
6 
 
Risk of developing chronic diseases such as obesity, type 2 diabetes, and cardiovascular 
disease increases with age.  This is partially due to aging-associated changes in body 
composition and hormone levels 9, 10, but may also be due to an imbalance in macronutrient 
intake11. It is recommended to consume an evenly distributed, moderate amount of high-quality 
protein at each meal12, but it is established that Western eating patterns are disproportionate, with 
lunch and dinner providing 31% and 41% of daily protein intake, respectively, snacks providing 
12%, and breakfast providing a mere 16%13.  Furthermore, protein-containing foods consumed at 
breakfast are often of low protein quality 14 resulting in inadequate consumption of essential 
amino acids (EEA) at the breakfast meal. Low consumption of EAA, such as tryptophan, may 
contribute to low tryptophan levels and increased mood disturbances15. It may also result in 
lower quality of life and increased risk for chronic disease and stress related mental disorders 15. 
Recent studies suggest that these factors may be reduced by whey protein supplementation 16, 
thereby improving overall diet and mood regulation, potentially through increased tryptophan in 
the diet. 
Whey protein isolate (WPI, 85-90% proteins) 17 has been associated with reduced desire 
to eat and increased feelings of fullness 11, indicating that WPI may be useful in regulating 
appetite.  This is congruent with the theory that the satiety effect can be manipulated by changing 
the macronutrient composition of diets 18. The Recommended Dietary Allowance (RDA) of 
tryptophan for adults 19 years and older is 0.005 g/kg/d 19. As the average weight of this study’s 
intervention participants is 73.4 kg ± 18.1 kg, the RDA for this participant pool would be 
approximately 0.3 g/d – 0.4 g/d – 0.5 g/d for participants weighing 55.3 kg – 73.4 kg – 91.5 kg, 
respectively. The Instantized BiPRO supplement used in this study contains approximately 0.8 g 
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of tryptophan per 25 g daily serving. Therefore, this supplement provides tryptophan in amounts 
greater than the RDA for these participants.  
Overall diet is influenced by sleep efficiency6. Tryptophan is the precursor to melatonin, 
which is involved in regulating the sleep-wake cycle 20. Low levels of melatonin are reflected by 
disturbances in the sleep-wake cycle and by the inability to sustain restful sleep. A lack of sleep 
increases food intake, snacking, and psychological distress 6.  Insufficient sleep also increases 
consumption of energy-rich foods in order to reduce psychological distress or relieve negative 
mood 6.  An increase in food intake, particularly high sodium- and carbohydrate-containing 
foods, contributes to the development of cardiovascular disease, obesity, and metabolic 
syndrome: hypertension, dyslipidemia, hyperglycemia, and abdominal obesity 21. Research 
suggests the risk for chronic disease and metabolic syndrome can be lowered by high quality-
protein via supplementation 9.  
Tryptophan, also a precursor to the neurotransmitter serotonin, influences mood 
regulation, emotional processing, and alertness 22. Mood regulation is important because it 
influences three factors that contribute to quality of life: choice of daily activities, choice of diet, 
and choice of sleep habits. In a 19-day randomized-controlled trial, a test drink containing 
tryptophan was administered twice per day; researchers found significant improvements in 
emotional processing and reduced sensitivity to negative stimuli 22. The results of this study 
suggest that high levels of tryptophan supplementation improve mood and mitigate depressive 
episodes 22.  
The objectives of this project were to 1) analyze the effects of high-quality whey protein 
intake on overall diet, and 2) identify and examine a correlation between tryptophan levels and 
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mood regulation. We hypothesized that 25-grams of whey protein isolate supplementation daily 
for 16 weeks would increase tryptophan levels, improve overall diet, and improve mood 
regulation in postmenopausal women.  
Materials and Methods 
Subject Recruitment and Participation 
Prior to subject recruitment, this study was submitted to the University of Arkansas’ 
Institutional Review Board for approval and was registered on clinicaltrials.gov, clinical trial 
number: NCT0303041. Participants were recruited from July 2018 through April 2020. 
Recruitment was ended earlier than anticipated to the COVID-19 epidemic. Participants were 
recruited voluntarily through advertisement in the University of Arkansas Newswire, social 
media, word-of-mouth, and flyers posted throughout the area. Eligibility required that 
participants were postmenopausal women with a last reported menstrual cycle of 12 months or 
more, were absent of hormone replacement therapy (HRT), have no known food allergies, 
regularly eat breakfast (<5 times per week), not taking medications that impact appetite, blood 
coagulation, metabolism, or blood lipids, not regularly consuming protein supplements, not 
consuming more than 0.8g/kg/day of protein (assessed via food frequency questionnaire), and 
have an initial Pittsburgh Sleep Quality Index (PSQI) of 5 or greater, as this score indicated 
dysregulated sleep. All subjects completed a phone screening and signed an informed consent 
form prior to enrolling. Participants were recruited on a rolling basis and were randomly 





This research was conducted using a randomized experimental design. A total of 13 post-
menopausal women (12+ months after last reported menstrual cycle) were recruited and 
allocated to one of two dietary intervention (DI) groups. The demographic of post-menopausal 
women was chosen to negate hormonal influence and to provide data on a population with 
limited available research. Upon acceptance into the study, participants were randomly assigned 
to 1 of 2 dietary intervention (DI) groups. The DI groups are as follows: 1) control (maintain 
current lifestyle; CON; n = 6), and 2) whey protein isolate (WPI; 25 g; n = 7).  Protein was 
consumed prior to 10:00 am daily. Both interventions were followed daily for 16 weeks.  
The WPI supplement, Instantized BiPRO, was given in 28 single-serving bags at the 
baseline, 4-, 8-, and 12-week laboratory visits. Participants were instructed to return empty 
supplement packages to the researchers upon the next visit to ensure compliance. 
All 5 laboratory visits required participants to arrive fasted with complete 3-day dietary 
logs. Participants completed the Pittsburgh Sleep Quality Index (PSQI) and Profile of Moods 
Questionnaire. Dietary logs were reviewed with participants. Height, weight, and waist-to-hip 
ratio was measured. A blood draw was administered by a certified phlebotomist to assess sleep 
and metabolic blood markers. Sleep was assessed at baseline, 8-, and 16-weeks.  
Educational Materials 
 Participants received a booklet corresponding to their randomly assigned intervention. 
All booklets contained a standard study day schedule and checklist, breakfast recipes that were 
modified to include protein powder for those participants assigned whey protein. 
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Body Composition, Anthropometrics, and Food Intake 
 Body composition was measured via DEXA at baseline and week 16.  Height, weight, 
and waist-to-hip ratio was measured at baseline, 4-, 8-, 12-, and 16-weeks. Height was measured 
to the nearest 0.01 cm using a stadiometer (Detecto, St. Louis, MO) with participants barefoot, in 
the free-standing position. Weight was measured to the nearest 0.01 kg using calibrated balance 
scales (Detecto, St. Louis, MO), with participants in the fasting state without shoes. Body mass 
index (BMI) was calculated as weight (kg) divided by height (m) squared. Waist measurements 
were taken at the level of the umbilicus using a soft tape measure and were rounded to the 
nearest 0.1 cm. Hip measurements were taken at the widest point below the waist using the soft 
tape measure and were rounded to the nearest 0.1 cm. Waist-to-hip ratios were recorded by 
dividing the waist measurement (cm) by the hip measurement (cm).  
At baseline, 4-, 8-, 12-, and 16-weeks, participants completed 3-day food records. 
Participants were trained to accurately record amounts of food using provided food scales 
(Greater Goods, LLC) and beverages. Participants were asked to record brand names and food 
preparation methods. A researcher reviewed the 3-day food records with the participants on each 
study day to confirm details. The Nutrition Data System for Research (Nutrition Coordinating 
Center, University of Minnesota, Minneapolis, MIN) analysis software was used to analyze the 
energy, micronutrient, and macronutrient composition of the 3-day food records.  
Mood 
Mood was assessed at baseline, 8-, and 16-weeks, via the Profile of Mood States (POMS) 
questionnaire. The POMS questionnaire has been validated in post-menopausal women1. The 
questionnaire consists of 65 questions containing a one-word adjective of mood to measure and 
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identify six affective states. Those states are tension, depression, anger, vigor, fatigue, and 
confusion. Participants define their mood on a 5-point Likert scale. Response options are 0 = not 
at all; 1 = a little; 2 = moderately; 3 = quite a lot; 4 = extremely. Researchers were available to 
answer questions regarding the meaning of a word.  
To score each affective state subscale, the sum of the responses for each adjective is 
calculated. Higher subscale scores for all except vigor represent a poor mood. The Total Mood 
Disturbance Score (TMD) is determined through the summation of the scores of the six factors 
(weighting vigor negatively). The total mood disturbance (TMD) is calculated by the following 
equation: 
TMD = (Tension - Anxiety) + (Depression - Dejection) + (Anger – Hostility) 
+ (Fatigue - Inertia) + (Confusion – Bewilderment) – (Vigor – Activity) 
Measurement of Tryptophan 
Tryptophan (and all amino acids) was measured using the commercially available EZ 
Faast amino acid analysis kit via GC/MS.  
Statistical Analysis 
One-way repeated measures analysis of variance (ANOVA) was used to assess the 
differences in BMI and POMS. One-way ANOVA was used to calculate the POMS Total Mood 
Disturbance scores. Clinical biomarker differences were determined through repeated-measures 
ANOVA (statistically significant: P < 0.05). Prism GraphPad Software Version 9.0 (La Jolla, 






 A total of 13 participants completed the study. Table 1 shows baseline participant 
characteristics, including: age, height, weight, body mass index (BMI), waist-to-hip ratio, and 
total mood disturbance POMS score. There were no differences in anthropometrics (Figure 1). 
Figure 2 indicates no change in BMI over the course of the intervention.  
TABLE 1. Baseline anthropometric characteristics of the study population by treatment group.1 
Baseline Characteristics Control (n = 6) PRO (n = 7) 
Age, y 63.0 ± 8.9 61.6 ± 8.4 
Anthropometrics   
   Height, m 1.62 ± 0.08 1.63 ± 0.06 
   Weight, kg 72.4 ± 15.2 73.4 ± 18.1 
   BMI, kg/m2 27.4 ± 4.6 27.4 ± 4.8 
   WHR 0.85 ± 0.05 0.85 ± 0.07 
Mood   
   POMS: TMD 6.3 ± 19.5 18.3 ± 33.0 
1Data are mean ± SDs. Significant differences: * P < 0.05. POMS: TMD = Total Mood 




FIGURE 1. Baseline anthropometrics for treatment groups.1 
1 Control, no intervention and free living, CON, n=6; whey protein isolate, PRO, n=7. (A) Baseline 
age in years. CON 63.0 ± 8.9; PRO 61.6 ± 8.4. (B) BMI in kg/m2. CON 27.4 ± 4.6; PRO 27.4 ± 
4.8. 
 
FIGURE 2. BMI changes over the course of the intervention.1 
 
1BMI in kg/m2.  
 
Tryptophan 
Tryptophan (and all amino acids) was measured using the commercially available EZ 
Faast amino acid analysis kit via GC/MS. Table 2 lists the nutrient composition of the whey 
protein isolate supplement. Notably, the WPI supplement contains approximately 0.8 g of 
tryptophan per serving. Table 3 indicates dietary tryptophan intake in the groups. Significant 
differences in tryptophan intake were found, with the WPI intervention group having a higher 
intake than the control. Figure 3 indicates a slight “U” shaped pattern of plasma tryptophan 
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levels over the course of the study. The trend for the control group starts high, decreases, then 
increases slightly but does not reach levels at baseline. The trend for the protein group indicates a 
decrease, then increase in plasma tryptophan levels.    
TABLE 2. Nutrient composition of dietary supplement.1  




Protein, g  25.5  
    Tryptophan, g  0.812 
Fat, g  0.4  
1The PRO represents a single dose (25 g) of whey protein isolate which participants consumed 
prior to 10:00 AM with breakfast daily. Whey protein isolate, PRO.  
 
 
TABLE 3. Dietary tryptophan profile in intervention and control groups.1 
Weeks of Intervention Treatment Effect2 ANCOVA P3 




    <0.01 <0.01 <0.01 <0.01 
   CON 0.83 ± 0.16 0.83 ± 0.21 0.89 ± 0.23 0.06 ± 0.20     
   PRO 1.03 ± 0.37 1.58 ± 0.45#$ 1.64 ± 0.41#$ 0.61 ± 0.46*     
1Values are mean ± SD. Control, no intervention and free living, CON, n=6; whey protein 
isolate, PRO, n=7. 
2Treatment effect between groups were tested by one-way ANOVA with baseline measurements 
subtracted from 16-week values. LS-means significant differences: * P < 0.05 
3Differences in raw data were analyzed at 0, 8, and 16 using ANCOVA with age and BMI as 
covariates. P-values are indicated for main effects of group and time and an interaction effect of 
group X time. * P < 0.05 for main effect of intervention; # significantly different from control 


















1Control, no intervention and free living, CON, n=6; whey protein isolate, PRO, n=7. Significant 
differences: * P < 0.05. Results insignificant. 
 
Diet 
Table 4 indicates the overall diet of both the WPI supplement group and the control group 
over the course of the study. Significant increases in protein intake, both g/kg/bw and %, were 





TABLE 4. Energy and macronutrient intake in dietary intervention and control groups.1 
 
Weeks of Intervention Treatment Effect2 ANCOVA P3 
Energy & 
Macronutrients 
0 8 16 Δ16 wk P Group Time Group 
X time 
Energy, kcal/d     0.27 0.60 0.73 0.84 
   CON 1757.3 ± 573.5 1963.3 ± 858.3 1844.6 ± 
490.9 
87.3 ± 170.8     
   PRO 2193.9 ± 
1403.0 




    
Protein, g/day     0.51 <0.01* 0.04* 0.12 
   CON 71.3 ± 18.6 69.9 ± 16.2 2.7 ± 19.7 1.4 ± 18.7     
   PRO 87.1 ± 35.9$ 90.8 ± 32.8 93.9 ± 31.5 6.8 ± 36.5     
Protein, %     0.29 <0.01* <0.01* <0.01* 
   CON 16.2 ± 1.6 15.4 ± 2.1 16.1 ± 3.2 -0.07 ± 4.22     
   PRO 18.9 ± 6.7 26.6 ± 9.0$# 23.6 ± 4.2$# 4.70 ± 6.13     
Protein, g/kg/bw     0.14 0.01 0.05 0.14 
   CON 0.99 ± 0.23 1.00 ± 0.027 1.01 ± 0.29 0.018 ± 0.274     
   PRO 1.23 ± 0.54 1.32 ± 0.62 1.6 ± 0.54 0.128 ± 0.548     
CHO, g/d     0.71 0.98 0.03* 0.49 
   CON 183.8 ± 70.3 204.6 ± 75.1 194.2 ± 46.3 10.3 ± 21.7     
   PRO 272.3 ± 202.7 178.2 ± 45.7 175.8 ± 42.3 -96.5 ± 192.8     
CHO, %     0.29 0.72 .15 0.27 
   CON 41.4 ± 6.1 42.3 ± 3.7 41.8 ± 9.9 0.36 ± 11.89     
   PRO 45.8 ± 11.4 44.5 ± 8.7 47.6 ± 7.3 1.79 ± 6.11     
Fat, g/d     0.79 0.65 0.27 0.14 
   CON 79.0 ± 30.7 83.1 ± 35.7 83.6 ± 33.8 4.6 ± 1.2     
   PRO 89.3 ± 64.0 55.8 ± 22.8 55.6 ± 17.6 -33.8 ± 60.4     
Fat, %     0.79 0.05 0.38 0.27 
   CON 39.0 ± 8.3$ 40.0 ± 5.3 38.2 ± 8.3 -0.82 ± 10.87     
   PRO 34.8 ± 6.5 30.0 ± 7.2 30.4 ± 4.6 -4.40 ± 3.89     
1Values are mean ± SD. Control, no intervention and free living, CON, n=6; whey protein 
isolate, PRO, n=6. 
2Treatment effect between groups were tested by one-way ANOVA with baseline measurements 
subtracted from 16-week values. LS-means significant differences: * P < 0.05 
3Differences in raw data were analyzed at 0, 8, and 16 using ANCOVA with age and BMI as 
covariates. P-values are indicated for main effects of group and time and an interaction effect of 
group X time. * P < 0.05 for main effect of intervention; # significantly different from control 






 Table 5 indicates POMS data over the course of the study. Results were  not significant. 




TABLE 5. Negative and positive affect states in the dietary intervention and control groups.1 
1Values are mean ± SD. Control, no intervention and free living, CON, n=6; whey protein 
isolate, PRO, n=7. POMS: TMD = Total Mood Disturbance (Sum of all subscales except Vigor 
minus Vigor), TMD score range (-32) to 200. All subscales are positive.  
2Treatment effect between groups were tested by one-way ANOVA with baseline measurements 
subtracted from 16-week values. LS-means significant differences: * P < 0.05 
3Differences in raw data were analyzed at 0, 8, and 16 using ANCOVA with age and BMI as 
covariates. P-values are indicated for main effects of group and time and an interaction effect of 
group X time. * P < 0.05 for main effect of intervention; # significantly different from control 
within time point following LS-means; $ significantly different compared to baseline follow LS-
means. 
Weeks of Intervention Treatment Effect2 ANCOVA P3 
POMS 0 8 16 Δ16 wk P Group Time Group X 
time 
Tension/Anxiety     0.83 0.58 0.28 0.79 
   CON 4.0 ± 3.3 3.7 ± 3.9 4.0 ± 3.8 0.0 ± 1.9     
   PRO 8.7 ± 6.9 7.0 ± 6.4 6.4 ± 5.5 -2.3 ± 6.5     
Depression     0.87 0.20 0.84 0.50 
   CON 3.0 ± 3.0 7.7 ± 13.6 2.7 ± 2.7 5.8 ± 5.8     
   PRO 7.4 ± 8.3 6.7 ± 9.8 8.1 ± 8.4 0.7 ± 7.3     
Anger     0.89 0.65 0.56 0.12 
   CON 3.8 ± 5.5 1.5 ± 2.5 3.0 ± 4.0 -0.8 ± 5.3     
   PRO 5.0 ± 3.4 5.9 ± 10.4 4.4 ± 7.9 -0.6 ± 6.7     
Fatigue     0.42 0.43 0.14 0.41 
   CON 6.5 ± 8.8 6.7 ± 6.1 8.5 ± 8.1 2.0 ± 4.6     
   PRO 9.1 ± 7.2 8.0 ± 6.1 4.9 ± 4.5 -4.3 ± 4.6     
Confusion     0.27 0.76 0.93 0.02 
   CON 5.3 ± 3.0 5.2 ± 3.8 5.7 ± 4.3 0.3 ± 2.0     
   PRO 6.6 ± 4.5 6.1 ± 4.1 3.6 ± 3.9 -3.0 ± 3.7     
Vigor     0.17 0.71 0.73 0.11 
   CON 16.3 ± 2.3 15.8 ± 5.5 12.3 ± 6.4 -4.0 ± 5.9     
   PRO 18.6 ± 6.9 23.0 ± 7.3 20.6 ± 9.1 2.0 ± 6.5     
TMD     0.71 0.71 0.73 0.11 
   CON 6.3 ± 19.5 3.8 ± 18.1 11.2 ± 
23.4 
4.8 ± 15.6     
   PRO 18.3 ± 33.0 10.7 ± 
37.8 
6.9 ± 32.6 -11.4 ± 
26.1 
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1Control, no intervention and free living, CON, n=6; whey protein isolate, PRO, n=7. Significant 
differences: * P < 0.05.  








1Control, no intervention and free living, CON, n=6; whey protein isolate, PRO, n=7. Significant 





In this 16-week study, tryptophan levels, mood, and food intake were evaluated in order 
to determine the effect of whey protein supplementation on post-menopausal women. Though 
the study size was relatively small, any significant effects could lead to a deeper understanding 
of the impact of whey protein supplementation on the health of post-menopausal women. 
There was no significant difference for body mass index, plasma tryptophan levels, and 
mood with 16-weeks of protein supplementation. Current research indicates that high-quality 
protein supplementation can reduce mood disturbances and stress related mental disorders15,16. 
Additionally, the literature suggests a positive impact of protein supplementation on overall 
mood, through improving sleep efficiency6. Our results were incongruent, though the sample size 
may have been too small for statistically significant improvements. Aside from increasing 
sample size, the addition of exercise or nutrition education to the intervention may be necessary 
for more informative results. 
Statistically significant results were found for protein intake; however, this would be 
expected since the intervention is a whey protein isolate supplement. These results are 
inconsistent with current literature, as some studies are finding significant results in regulating 
mood with protein supplements24; however, the composition of said supplements may be 
different from the Instantized BiPRO supplement used in this study. 
There are several notable strengths of this study. First, on laboratory days, shakes were 
delivered in opaque containers, with lids and straws. Second, we provided recipes to both 
intervention groups, with modifications for the protein group; this increased the probability of 
compliance by increasing palatability of the whey protein. Additionally, most of the 3-day food 
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record data was uploaded to the Nutrition Data System for Research (Nutrition Coordinating 
Center, University of Minnesota, Minneapolis, MIN) analysis software by the same researcher. 
Finally, there was low participant anthropometric variability. 
However, there were several limitations to this study. First, the food records were not 
reviewed by a registered dietitian. This does increase risk of missing food record data. Second, 
food records are not 100% reliable, as information is recorded by the participant, not the 
researcher. Additionally, protein supplement compliance cannot be verified with absolute 
certainty, though biomarker trends will support compliance. 
Further research is necessary to determine a correlation between whey protein isolate and 
tryptophan levels, overall diet, and mood regulation in postmenopausal women. High-quality 
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